HC Wainwright & Co. Reiterates Buy on Belite Bio, Maintains $185 Price Target
Benzinga Newsdesk 9 months ago
NewsPrice TargetReiterationAnalyst Ratings
HC Wainwright & Co. analyst Yi Chen reiterates Belite Bio (NASDAQ:BLTE) with a Buy and maintains $185 price target.
HC Wainwright & Co. analyst Yi Chen reiterates Belite Bio (NASDAQ:BLTE) with a Buy and maintains $185 price target.